Switch from prednisone to dexamethasone in patients with...

European Urology Supplements 2019 / 11 Vol. 18; Iss. 11

Switch from prednisone to dexamethasone in patients with metastatic castration resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) in a multicenter study

Rivero Belenchón, I., Muñoz Calahorro, C., Osmán García, I., Beardo Villar, P., Congregado Ruíz, C.B., San José Ruíz Jiménez, B., Campé Bortolo, J., Llarena Ibarguren, R., Extramiana Cameno, J., Medin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)34626-3
Date:
November, 2019
File:
PDF, 142 KB
2019
Conversion to is in progress
Conversion to is failed